Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
Cross-Atlantic researchers have developed two AI models that are fast and accurate at screening for COVID-19, offering hospitals potential options when lab testing is backed up or unavailable.
Asked to identify which of six fictional persons is most likely to be a terrorist, 85% of 1,500 participants in a psychology experiment selected one of the least likely suspects. And they did so specifically because they’d seen an AI robot make the ridiculous choice first.
Researchers have used AI-powered risk prediction to accurately screen the entire inpatient population of a community hospital for sepsis, enabling early treatment of the stricken.
Going by biomarkers of inflammation, taking care of aging or ailing loves ones is not detrimental to the caregiver’s own health and wellbeing. In fact, it may even make one healthier.
Healthcare AI watchers would be unwise to overlook dermatology, as it is a medical specialty “at the precipice of an artificial intelligence revolution.”
As researchers have turned to AI for battling COVID-19, raising hopes and making headlines, the shortcomings of the studies have drawn the ire of numerous statistics experts.
It’s a painful paradox that hospitals can help COVID patients recover while helping the virus spread—and not only to non-COVID patients but also to healthcare workers, support staff and even visitors.
